Vertex Pharmaceuticals Incorporated (VRTX), operates as Biotechnology company in the United States, Europe & internationally. It offers transformative medicines for people with serious diseases of different age groups. It comes under Healthcare – Biotech sector & trades as “VRTX” ticker at Nasdaq.
In weekly, VRTX confirmed higher high above November-2024 high expected in last article. It should continue rally towards 556.9 – 591 area in shorter cycle within May-2026 sequence. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
VRTX - Elliott Wave Latest Weekly View:
In weekly, it placed ((I)) at $306.08 high (July-2020) & ((II)) at $176.36 low (October-2021). Above there, it ended (I) of ((III)) at $519.88 high (November-2024) & (II) at $362.50 low (August-2025). Within (I), it ended I at $292.75 high, II at $233.01 low, III at $510.63 high, IV at $447.70 low & V at $519.88 high. Within extended III, it placed ((1)) at $324.75 high, ((2)) at $282.21 low, ((3)) at $448.40 high, ((4)) at $391.01 low & ((5)) at $510.63 high. It ended (II) in double three correction. It ended w at $377.85 low in December-2024, x at $519.68 high in March-2025 & y at $362.50 low in August-2025.
VRTX - Elliott Wave View From 3.23.2026:
Above $362.50 low, it ended ((1)) at $507.92 high, ((2)) at $412.27 low & favors rally in ((3)) towards $556.87- $646.41 area. It ended (1) of ((1)) at $403.58 high, (2) at $374.17 low, (3) at $487.52 high, (4) at $450.67 low & (5) at $507.92 high. As expected, it ended ((2)) in price channel against August-2025 before rally continue. Within ((3)), it ended (1) at $456.68 high, (2) at $420.01 low & favors rally in (3). It expects five swings to unfold above $556.87 to finish ((3)). The rally can either in ((3)) as conservative view or can be (1) of ((3)) in more bullish case, if extends more. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
